Embla Medical hf.: Embla Medical hf: Notice to 2026 Annual General Meeting
Announcement no. 9/2026
17 February 2026
Reykjavik, Iceland/Copenhagen, Denmark, February 17, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that Embla Medical's Annual General Meeting will be held on Tuesday 10 March 2026 at 9:00 AM (GMT) at the Company's headquarters at Grjótháls 1-5, Reykjavík, Iceland.
The convocation can be found enclosed to this announcement and includes the proposed agenda for the Annual General Meeting and information on shareholders' participation and registration, shareholders' rights, voting and proxies, and other practical matters, as well as the proposed resolutions and remarks on each item on the agenda.
Further information
Klaus Sindahl, Head of Investor Relations, KSindahl@emblamedical.com, +45 5363 0134
Embla Medical press releases by e-mail
If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Embla Medical is home to several leading brands renowned for positively impacting people's health and well-being. They include Össur, a leading global provider of prosthetics and bracing solutions; Fior & Gentz, an innovative developer of neuro orthotics; College Park, a provider of lower limb prosthetics; and ForMotion, a global network of Orthotic and Prosthetic (O&P) patient care facilities. Embla Medical is committed to sustainable business practices, is a signatory to the UN Global Compact and UN Women's Empowerment Principles and contributes to the UN Sustainable Development Goals. The company's climate targets have been verified by the Science Based Targets initiative. Embla Medical operates globally and has around 4,500 employees. www.emblamedical.com